Recent federal data indicate a notable decline in the number of Americans diagnosed with alcohol use disorder (AUD) over the past five years. According to the 2025 report from the National Survey on Drug Use and Health, conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA), the prevalence of AUD among individuals aged 12 and older fell to 8.9 percent in 2025, down from 10.6 percent in 2021. This decrease translates to nearly four million fewer people meeting the diagnostic criteria.

The annual survey’s methodology was revised during the COVID-19 pandemic, limiting direct comparisons to data before 2021. However, experts say the decline aligns with trends observed in independent surveys, including those conducted by Gallup and the University of Michigan, which also report reductions in alcohol consumption.

Alcohol use disorder refers to patterns of drinking that a person cannot control despite negative effects on their health, work, and relationships. The diagnosis is based on the presence of symptoms such as cravings, drinking more than intended, and unsuccessful attempts to cut down. Clinicians categorize AUD severity by the number of symptoms present: mild (two to three symptoms), moderate (four to five), and severe (six or more).

The federal data reveal that the largest drop occurred among individuals with mild AUD, who make up the majority of those diagnosed. Their numbers decreased by nearly 20 percent, or close to three million people. Moderate and severe cases saw smaller declines. Public health specialists emphasize that even this reduction among mild cases represents a significant improvement, as these individuals constitute the largest group affected.

Experts attribute the shift to changing social and cultural factors rather than any single cause. Since the early 2000s, younger generations have tended to drink less, carrying these habits into adulthood. Increasing public awareness regarding alcohol’s health risks—including its links to various cancers highlighted in a 2025 Surgeon General advisory—may also be influencing behavior. Additionally, some individuals may be using alternatives such as cannabis.

There is also interest in whether the rising use of semaglutide-based medications, originally for weight loss but found to reduce alcohol cravings, has contributed to the decline. However, researchers caution that these medications primarily affect the heaviest drinkers, and since severe AUD cases have decreased less, semaglutide is unlikely to explain the broader trend.

The reduction in alcohol use disorder emerges amid a rollback of federal emphasis on alcohol as a public health concern. In 2025, the government revised its dietary guidelines, replacing specific drink limits for men and women with a more general recommendation to limit intake. At the same time, federal funding and personnel dedicated to alcohol-related programs have been significantly reduced, including cuts to the Centers for Disease Control and Prevention’s alcohol program.

Public health officials stress the importance of sustained prevention efforts to maintain progress. For individuals concerned about their drinking, clinicians recommend discussing the issue with healthcare providers who can offer counseling, medications, or referrals to specialized treatment. Resources such as the National Institute on Alcohol Abuse and Alcoholism’s Rethinking Drinking website are also endorsed as tools to evaluate and reduce alcohol consumption.

Whether the recent declines in AUD continue remains uncertain, particularly in light of evolving federal policies and shrinking public health infrastructure. Experts warn that without renewed investment in prevention and treatment, gains may stall or reverse.